Table of Content

1. Executive Summary


2. Introduction

2.1 Anesthesia: An Overview
2.1.1 Definition of Anesthesia

2.2 Anesthesia Segmentation: An Overview
2.2.1 Anesthesia Segmentation


3. Market Analysis

3.1 The US Anesthesia Drugs and Devices Market: An Analysis

3.1.1 The US Anesthesia Drugs and Devices Market: An Overview
3.1.2 The US Anesthesia Drugs and Devices Market by Value
3.1.3 The US Anesthesia Drugs and Devices Market by Segment (Anesthesia Drugs And Anesthesia Devices)

3.2 The US Anesthesia Drugs and Devices Market: Segment Analysis

3.2.1 The US Anesthesia Drugs Market by Segment: An Overview
3.2.2 The US Anesthesia Drugs Market by Value
3.2.3 The US Anesthesia Drugs Market by Type (General, Local And Other Anesthesia)
3.2.4 The US Anesthesia Devices Market by Value
3.2.5 The US Anesthesia Devices Market by Product (Advanced, Basic And Integrated)

3.3 The US Anesthesia Drugs Market: Type Analysis

3.3.1 The US Anesthesia Drugs Market by Type: An Overview
3.3.2 The US General Anesthesia Drugs Market by Value
3.3.3 The US Local Anesthesia Drugs Market by Value
3.3.4 The US Local Anesthesia Drugs Market by Product (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine and Other Local Anesthetics)
3.3.5 The US Other Anesthesia Drugs Market by Value

3.4 The US Local Anesthesia Drugs Market: Product Analysis

3.4.1 The US Local Anesthesia Drugs Market by Product: An Overview
3.4.2 The US Lidocaine Anesthesia Drugs Market by Value
3.4.3 The US Bupivacaine Anesthesia Drugs Market by Value
3.4.4 The US Ropivacaine Anesthesia Drugs Market by Value
3.4.5 The US Prilocaine Anesthesia Drugs Market by Value
3.4.6 The US Benzocaine Anesthesia Drugs Market by Value
3.4.7 The US Chloroprocaine Anesthesia Drugs Market by Value
3.4.8 The US Other Local Anesthesia Drugs Market by Value

3.5 The US Anesthesia Devices Market: Product Analysis

3.5.1 The US Anesthesia Devices Market by Product: An Overview
3.5.2 The US Advanced Anesthesia Devices Market by Value
3.5.3 The US Integrated Anesthesia Devices Market by Value
3.5.4 The US Basic Anesthesia Devices Market by Value


4. Impact of COVID-19

4.1 Impact of COVID-19 on Anesthesia Drugs And Devices Market
4.2 Response of Industry
4.3 The US Number of COVID-19 Total Cases


5. Market Dynamics

5.1 Growth Drivers
5.1.1 Rising Geriatric Population
5.1.2 Growing Healthcare Expenditure
5.1.3 Increase in Monitored Anesthesia Use
5.1.4 Increase In Number Of Approval For Anesthesia Drugs

5.2 Challenges
5.2.1 Side Effects of Anesthesia
5.2.2 Lack of Skilled Anesthesiologist

5.3 Market Trends
5.3.1 Escalating Establishment of Ambulatory Surgical Centers (ASC)
5.3.2 Technological Enhancement of Anesthesia Devices


6. Competitive Landscape

6.1 The US Anesthesia Hospital Players by Market Share
6.2 The US Anesthesia Service Market by Other Private Providers
6.3 The US Anesthesiology Service Market Players by Services


7. Company Profiles

7.1 KKR & Co. Inc. (Envision Healthcare Corporation)
7.1.1 Business Overview
7.1.2 Business Strategy

7.2 Baxter International Inc.
7.2.1 Business Overview
7.2.2 Operating Segment
7.2.3 Business Strategy

7.3 Blackstone (TeamHealth)
7.3.1 Business Overview
7.3.2 Business Strategy

7.4 Becton, Dickinson and Company
7.4.1 Business Overview
7.4.2 Operating Segment
7.4.3 Business Strategy

7.5 Braun (B. Braun Avitum AG)
7.5.1 Business Overview
7.5.2 Sales by Division
7.5.3 Business Strategy

7.6 3M Company
7.6.1 Business Overview
7.6.2 Operating Segment
7.6.3 Business Strategy

7.7 Abbvie Inc.
7.7.1 Business Overview
7.7.2 Net Revenue by Therapeutic Area
7.7.3 Business Strategy

7.8 Teleflex Incorporated
7.8.1 Business Overview
7.8.2 Operating Segment
7.8.3 Business Strategy

7.9 Dr?gerwerk AG & Co. KGaA
7.9.1 Business Overview
7.9.2 Net Sales by Division
7.9.3 Business Strategy

7.10 AstraZeneca Plc
7.10.1 Business Overview
7.10.2 Total Revenue by Disease Areas
7.10.3 Business Strategies

7.11 Abbott Laboratories
7.11.1 Business Overview
7.11.2 Operating Segment
7.11.3 Business Strategy

7.12 General Electric Company
7.12.1 Business Overview
7.12.2 Operating Segment
7.12.3 Business Strategy

7.13 ICU Medical, Inc.
7.13.1 Business Overview
7.13.2 Revenues by Geography
7.13.3 Business Strategy

7.14 SunMed LLC
7.14.1 Business Overview
7.14.2 Business Strategy

List of Figures

Figure 1: Anesthesia: Side Effects
Figure 2: Anesthesia Segmentation
Figure 3: The US Anesthesia Drugs and Devices Market by Value; 2017-2021 (US$ Billion)
Figure 4: The US Anesthesia Drugs and Devices Market by Value; 2022-2027 (US$ Billion)
Figure 5: The US Anesthesia Drugs Market by Segment; 2021 (Percentage, %)
Figure 6: The US Anesthesia Drugs Market by Value; 2017-2021 (US$ Billion)
Figure 7: The US Anesthesia Drugs Market by Value; 2022-2027 (US$ Billion)
Figure 8: The US Anesthesia Drugs Market by Type; 2021 (Percentage, %)
Figure 9: The US Anesthesia Devices Market by Value; 2017-2021 (US$ Billion)
Figure 10: The US Anesthesia Devices Market by Value; 2022-2027 (US$ Billion)
Figure 11: The US Anesthesia Devices Market by Product; 2021 (Percentage, %)
Figure 12: The US General Anesthesia Drugs Market by Value; 2017-2021 (US$ Billion)
Figure 13: The US General Anesthesia Drugs Market by Value; 2022-2027 (US$ Billion)
Figure 14: The US Local Anesthesia Drugs Market by Value; 2017-2021 (US$ Billion)
Figure 15: The US Local Anesthesia Drugs Market by Value; 2022-2027 (US$ Billion)
Figure 16: The US Local Anesthesia Drugs Market by Product; 2021 (Percentage, %)
Figure 17: The US Other Anesthesia Drugs Market by Value; 2017-2021 (US$ Million)
Figure 18: The US Other Anesthesia Drugs Market by Value; 2022-2027 (US$ Billion)
Figure 19: The US Lidocaine Anesthesia Drugs Market by Value; 2017-2021 (US$ Million)
Figure 20: The US Lidocaine Anesthesia Drugs Market by Value; 2022-2027 (US$ Million)
Figure 21: The US Bupivacaine Anesthesia Drugs Market by Value; 2017-2021 (US$ Million)
Figure 22: The US Bupivacaine Anesthesia Drugs Market by Value; 2022-2027 (US$ Million)
Figure 23: The US Ropivacaine Anesthesia Drugs Market by Value; 2017-2021 (US$ Million)
Figure 24: The US Ropivacaine Anesthesia Drugs Market by Value; 2022-2027 (US$ Million)
Figure 25: The US Prilocaine Anesthesia Drugs Market by Value; 2017-2021 (US$ Million)
Figure 26: The US Prilocaine Anesthesia Drugs Market by Value; 2022-2027 (US$ Million)
Figure 27: The US Benzocaine Anesthesia Drugs Market by Value; 2017-2021 (US$ Million)
Figure 28: The US Benzocaine Anesthesia Drugs Market by Value; 2022-2027 (US$ Million)
Figure 29: The US Chloroprocaine Anesthesia Drugs Market by Value; 2017-2021 (US$ Million)
Figure 30: The US Chloroprocaine Anesthesia Drugs Market by Value; 2022-2027 (US$ Million)
Figure 31: The US Other Local Anesthesia Drugs Market by Value; 2017-2021 (US$ Million)
Figure 32: The US Other Local Anesthesia Drugs Market by Value; 2022-2027 (US$ Million)
Figure 33: The US Advanced Anesthesia Devices Market by Value; 2017-2021 (US$ Billion)
Figure 34: The US Advanced Anesthesia Devices Market by Value; 2022-2027 (US$ Billion)
Figure 35: The US Integrated Anesthesia Devices Market by Value; 2017-2021 (US$ Million)
Figure 36: The US Integrated Anesthesia Devices Market by Value; 2022-2027 (US$ Million)
Figure 37: The US Basic Anesthesia Devices Market by Value; 2017-2021 (US$ Million)
Figure 38: The US Basic Anesthesia Devices Market by Value; 2022-2027 (US$ Million)
Figure 39: The US Number of COVID-19 Total Cases, 2020-2022 (Million)
Figure 40: The US Old Age Population (65 years and Older); 2016-2021 (Percentage,%)
Figure 41: The US National Health Expenditure; 2021-2028 (US$ Trillion)
Figure 42: The US Ambulatory Surgical Centers; 2020-2025 (US$ Billion)
Figure 43: The US Anesthesia Hospital Players by Market Share; 2021 (Percentage, %)
Figure 44: Baxter International Inc. Net Sales by Segment; 2021 (Percentage, %)
Figure 45: Becton, Dickinson and Company Revenues by Segment; 2021 (Percentage, %)
Figure 46: B. Braun Sales by Division; 2021 (Percentage, %)
Figure 47: 3M Company Net Sales by Segment; 2021 (Percentage, %)
Figure 48: Abbvie Inc. Net Revenue by Therapeutic Area; 2021 (Percentage, %)
Figure 49: Teleflex Incorporated Net Revenues by Segments; 2021 (Percentage, %)
Figure 50: Dr?gerwerk AG & Co. KGaA Net Sales by Division; 2021 (Percentage, %)
Figure 51: AstraZeneca Total Revenue by Disease Areas; 2021 (Percentage, %)
Figure 52: Abbott Laboratories Sales by Segment; 2021 (Percentage, %)
Figure 53: General Electric Company Revenue by Segment; 2021 (Percentage,%)
Figure 54: ICU Medical, Inc. Revenues by Geography; 2021 (Percentage,%)
Table 1: The US Anesthesia Service Market by Other Private Providers
Table 2: The US Anesthesiology Service Market Players by Services